
    
      We'd like to investigate the 2-year incidence rate of brain metastases in completed or
      partial remission limited small cell lung cancer patients who received temozolomide only for
      12 months or 25-30Gy prophylactic cranial radiotherapy in preventing brain metastases.
    
  